BioCentury | Nov 7, 2005
Product Development

Nabi chronicles

...Monday date prior to the week the event occurred. A. 11/29/95 - NABI, then called North American Biologicals Inc....
BioCentury | Jan 22, 1996
Company News

North American Bio blood products/substitutes news

...to NABI. As of Jan. 18, the company's stock began trading under the symbol "NABI". North American Biologicals Inc....
BioCentury | Jan 22, 1996
Clinical News

HyperGam polyclonal antibody: NBIO completed the U.S.

...two companies sharing development costs and profits. (North American Biologicals renamed NABI, see Other News). North American Biologicals Inc....
BioCentury | Jan 15, 1996
Strategy

How plasma market shapes up

...creation of Centeon, a major new supplier of specialty plasma, should be a plus for North American Biologicals Inc....
BioCentury | Dec 4, 1995
Company News

North American Bio, Univax deal

...R&D will be headquartered in Rockville. The merged company will trade under the symbol NBIO. North American Biologicals Inc....
BioCentury | Nov 13, 1995
Company News

North American Bio blood products news

...operations to three. All of the centers are licensed for the collection of specialty plasma. North American Biologicals Inc....
BioCentury | Oct 23, 1995
Clinical News

North American Bio, Univax regulatory update

...pertaining the proposed merger of UNVX (Rockville, Md.) and NBIO (Miami). (see BioCentury Sept. 5). North American Biologicals Inc....
BioCentury | Sep 5, 1995
Analyst Picks & Changes

Analyst picks & changes

North American Biologicals Inc. (NBIO) Univax Biologics Inc. (UNVX) Business: Autoimmune, Blood Substitutes/Products, Infectious disease Raymond James analyst Donald Hultgren repeated a "buy" on NBIO (Boca Raton, Fla.) with a 12-month price target of $16-$20,...
BioCentury | Sep 5, 1995
Strategy

New products + mature business = merger

...collection centers and manufacturing facilities, last week solved its dilemma by agreeing to merge with North American Biologicals Inc....
BioCentury | Sep 5, 1995
Strategy

Leverage for Chiron's vaccines

...Leverage for Chiron's vaccines Concurrently with the merger agreement between Univax Biologics Inc. and North American Biologicals Inc....
Items per page:
1 - 10 of 21
BioCentury | Nov 7, 2005
Product Development

Nabi chronicles

...Monday date prior to the week the event occurred. A. 11/29/95 - NABI, then called North American Biologicals Inc....
BioCentury | Jan 22, 1996
Company News

North American Bio blood products/substitutes news

...to NABI. As of Jan. 18, the company's stock began trading under the symbol "NABI". North American Biologicals Inc....
BioCentury | Jan 22, 1996
Clinical News

HyperGam polyclonal antibody: NBIO completed the U.S.

...two companies sharing development costs and profits. (North American Biologicals renamed NABI, see Other News). North American Biologicals Inc....
BioCentury | Jan 15, 1996
Strategy

How plasma market shapes up

...creation of Centeon, a major new supplier of specialty plasma, should be a plus for North American Biologicals Inc....
BioCentury | Dec 4, 1995
Company News

North American Bio, Univax deal

...R&D will be headquartered in Rockville. The merged company will trade under the symbol NBIO. North American Biologicals Inc....
BioCentury | Nov 13, 1995
Company News

North American Bio blood products news

...operations to three. All of the centers are licensed for the collection of specialty plasma. North American Biologicals Inc....
BioCentury | Oct 23, 1995
Clinical News

North American Bio, Univax regulatory update

...pertaining the proposed merger of UNVX (Rockville, Md.) and NBIO (Miami). (see BioCentury Sept. 5). North American Biologicals Inc....
BioCentury | Sep 5, 1995
Analyst Picks & Changes

Analyst picks & changes

North American Biologicals Inc. (NBIO) Univax Biologics Inc. (UNVX) Business: Autoimmune, Blood Substitutes/Products, Infectious disease Raymond James analyst Donald Hultgren repeated a "buy" on NBIO (Boca Raton, Fla.) with a 12-month price target of $16-$20,...
BioCentury | Sep 5, 1995
Strategy

New products + mature business = merger

...collection centers and manufacturing facilities, last week solved its dilemma by agreeing to merge with North American Biologicals Inc....
BioCentury | Sep 5, 1995
Strategy

Leverage for Chiron's vaccines

...Leverage for Chiron's vaccines Concurrently with the merger agreement between Univax Biologics Inc. and North American Biologicals Inc....
Items per page:
1 - 10 of 21